← Back to Search

Fuji Flim Processor VP-7000, Light Source BL-7000 for Gastrointestinal Disorder

N/A
Waitlist Available
Led By Kenneth Wang, MD
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up approximately one year
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing a special camera called the Fujifilm 4-LED system during routine endoscopies at Mayo Clinic. It uses different types of light to help doctors see unhealthy tissue more clearly. The goal is to improve the accuracy of identifying abnormal tissues.

Eligible Conditions
  • Gastrointestinal Disorder

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~approximately one year
This trial's timeline: 3 weeks for screening, Varies for treatment, and approximately one year for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Number of Subjects Whose Endoscopic Images Correlated With Final Clinical and Histological Diagnosis

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Fuji Flim Processor VP-7000Experimental Treatment1 Intervention
Screening or surveillance colonoscopy using Fuji Flim Processor VP-7000, Light Source BL-7000
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Fuji Flim Processor VP-7000, Light Source BL-7000
2017
N/A
~360

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor
3,316 Previous Clinical Trials
2,954,116 Total Patients Enrolled
3 Trials studying Gastrointestinal Disorder
770 Patients Enrolled for Gastrointestinal Disorder
Fujifilm Medical Systems USA, Inc.Industry Sponsor
13 Previous Clinical Trials
4,633 Total Patients Enrolled
Kenneth Wang, MDPrincipal InvestigatorMayo Clinic
6 Previous Clinical Trials
426 Total Patients Enrolled
~44 spots leftby Oct 2025